Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Peptic Ulcer Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size for peptic ulcers has been expanding progressively. The market growth is projected to rise from $4.1 billion in 2024 to $4.22 billion in 2025 at a steady compound annual growth rate (CAGR) of 3.0%. The past period growth is primarily due to the growing occurrences of helicobacter pylori infection, increased consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), alterations in lifestyle and eating routines, expanded awareness through campaigns and educational drives, and an emphasis on managing stress.

In the coming years, the market size for peptic ulcers is anticipated to witness consistent growth. It is projected to increase to$4.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 3.8%. Factors contributing to this growth during the forecast period include the advent of new therapies and treatments, an ageing population, the incorporation of precision medicine, preventive strategies and health advancement, as well as ongoing research and clinical trials. Key trends during this period encompass digital health care solutions, progress in treatment methods, a rising incidence of helicobacter pylori infection, the merging of diagnostic imaging technologies, and an elevated use of combination therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Peptic Ulcer Market?

The increasing trend of obesity is predicted to boost the expansion of the peptic ulcer market in future. Obesity, a health disorder typified by excessive accumulation of body fat leading to a body mass index (BMI) of 30 or above, can be caused by genetic, environmental, and lifestyle factors including poor dietary habits and insufficient physical exercise. This condition fosters the overproduction of gastric acid, weakens the protection of the stomach’s mucosal lining, and aids in the formation of peptic ulcers. Furthermore, additional weight seems to incite inflammation in the digestive tract, which can culminate in peptic ulcers. For example, data from the Centers for Disease Control and Prevention, a public health agency in the US, revealed that between August 2021 and August 2023, the obesity rate among adults stood at 40.3%, with 39.2% prevalence in men and 41.3% in women. Consequently, the escalating trend of obesity is fueling the growth of the peptic ulcer market.

Which Key Market Segments Comprise the Peptic Ulcer Market and Drive Its Revenue Growth?

The peptic ulcermarket covered in this report is segmented –

1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)

2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs

3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce

Subsegments:

1) By Gastritis: Acute Gastritis; Chronic Gastritis

2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer

3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer

4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp

Which Areas Are Leading Regions in the Peptic Ulcer Market Expansion Across the Globe?

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in thePeptic Ulcer Market Over the Coming Years?

Firms active in the peptic ulcer market are working on unique product formulation and treatments, securing regulatory acceptances to establish a competitive advantage. The creation of drugs is a vital component in peptic ulcer care, benefiting symptom control, healing process, complication prevention, and treatment of the root issue. For example, in April 2023, Indian pharmaceutical firm Akums Drugs and Pharmaceutical Ltd. introduced its newest formulation, the Combikit, comprising of Amoxicillin, Clarithromycin, and Esomeprazole. The Central Drugs Standard Control Organisation (CDSCO) has endorsed this Combikit for the treatment of duodenal ulcers related to Helicobacter pylori (H. pylori) and for the elimination of H. pylori from patients with active or healed peptic ulcers. The H. pylori-targeting treatment has shown efficacy in reducing ulcer recurrence risk, proving significantly valuable to patients. H. pylori is a common infection in India and is linked with gastritis and peptic ulcer development.

View the full report here:

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

How Is the Peptic Ulcer Market Conceptually Defined?

A peptic ulcer is an open sore or raw area in the stomach lining or intestine. It is primarily caused by the erosion of the stomach’s protective lining or the upper part of the small intestine (duodenum). The common peptic ulcer symptoms include upper abdominal pain or discomfort and acid reflux symptoms like heartburn, sometimes accompanied by nausea.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13221

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model